☰

Michael Zigmond - Publications

Affiliations: 
Pittsburgh 
Area:
Parkinson's disease, neurology
Tree Info Grants Similar researchers PubMed Report error

145/260 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Heng V, Zigmond M, Smeyne RJ. Neuroanatomical and neurochemical effects of prolonged social isolation in adult mice. Frontiers in Neuroanatomy. 17: 1190291. PMID 37662476 DOI: 10.3389/fnana.2023.1190291  0.488
2016 Parra LA, Baust TB, Smith AD, Jaumotte JD, Zigmond MJ, Torres S, Leak RK, Pino JA, Torres GE. The Molecular Chaperone Hsc70 Interacts with Tyrosine Hydroxylase to Regulate Enzyme Activity and Synaptic Vesicle Localization. The Journal of Biological Chemistry. PMID 27365397 DOI: 10.1074/jbc.M116.728782  0.642
2016 Ayadi AE, Zigmond MJ, Smith AD. IGF-1 protects dopamine neurons against oxidative stress: association with changes in phosphokinases. Experimental Brain Research. PMID 26894890 DOI: 10.1007/s00221-016-4572-1  0.301
2015 Parmar MS, Jaumotte JD, Zigmond MJ, Cavanaugh JE. ERK1, 2, and 5 expression and activation in dopaminergic brain regions during postnatal development. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 46: 44-50. PMID 26363522 DOI: 10.1016/J.Ijdevneu.2015.06.009  0.311
2014 Jaumotte JD, Zigmond MJ. Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures. Journal of Neuroscience Research. 92: 1425-33. PMID 24916473 DOI: 10.1002/jnr.23425  0.367
2014 Zigmond MJ, Smeyne RJ. Exercise: is it a neuroprotective and if so, how does it work? Parkinsonism & Related Disorders. 20: S123-7. PMID 24262162 DOI: 10.1016/S1353-8020(13)70030-0  0.616
2012 Zigmond MJ, Cameron JL, Hoffer BJ, Smeyne RJ. Neurorestoration by physical exercise: moving forward. Parkinsonism & Related Disorders. 18: S147-50. PMID 22166417 DOI: 10.1016/S1353-8020(11)70046-3  0.566
2011 El Ayadi A, Zigmond MJ. Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study. Plos One. 6: e24722. PMID 22022363 DOI: 10.1371/journal.pone.0024722  0.68
2011 Cohen AD, Zigmond MJ, Smith AD. Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: time course of protection and neurorestoration. Brain Research. 1370: 80-8. PMID 21062624 DOI: 10.1016/J.Brainres.2010.11.006  0.64
2010 Leak RK, Castro SL, Jaumotte JD, Smith AD, Zigmond MJ. Assaying multiple biochemical variables from the same tissue sample. Journal of Neuroscience Methods. 191: 234-8. PMID 20600314 DOI: 10.1016/j.jneumeth.2010.06.023  0.319
2010 Zigmond M, Smeyne RJ. Foreword: exercise and the brain. Brain Research. 1341: 1-2. PMID 20538145 DOI: 10.1016/J.Brainres.2010.05.053  0.542
2009 Zigmond MJ, Cameron JL, Leak RK, Mirnics K, Russell VA, Smeyne RJ, Smith AD. Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism & Related Disorders. 15: S42-5. PMID 20083005 DOI: 10.1016/S1353-8020(09)70778-3  0.638
2008 Pienaar IS, Kellaway LA, Russell VA, Smith AD, Stein DJ, Zigmond MJ, Daniels WM. Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: implications for neurodegenerative disorders. Stress (Amsterdam, Netherlands). 11: 448-56. PMID 18609296 DOI: 10.1080/10253890801890721  0.34
2008 Lindgren N, Leak RK, Carlson KM, Smith AD, Zigmond MJ. Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease. Journal of Neuroscience Research. 86: 2039-49. PMID 18438911 DOI: 10.1002/jnr.21641  0.318
2008 Leak RK, Zigmond MJ. Endogenous Defenses that Protect Dopamine Neurons. Studies with 6-ohda Models of Parkinson's Disease Parkinson's Disease. 173-194. DOI: 10.1016/B978-0-12-374028-1.00013-0  0.345
2006 Zigmond MJ. Triggering endogenous neuroprotective mechanisms in Parkinson's disease: studies with a cellular model. Journal of Neural Transmission. Supplementum. 439-42. PMID 17017565  0.337
2006 Dishman RK, Berthoud HR, Booth FW, Cotman CW, Edgerton VR, Fleshner MR, Gandevia SC, Gomez-Pinilla F, Greenwood BN, Hillman CH, Kramer AF, Levin BE, Moran TH, Russo-Neustadt AA, Salamone JD, ... ... Zigmond MJ, et al. Neurobiology of exercise. Obesity (Silver Spring, Md.). 14: 345-56. PMID 16648603 DOI: 10.1038/Oby.2006.46  0.452
2005 Smith AD, Kozlowski DA, Bohn MC, Zigmond MJ. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats. Experimental Neurology. 193: 420-6. PMID 15869944 DOI: 10.1016/J.Expneurol.2005.01.010  0.466
2005 Jaumotte JD, Zigmond MJ. Dopaminergic innervation of forebrain by ventral mesencephalon in organotypic slice co-cultures: effects of GDNF. Brain Research. Molecular Brain Research. 134: 139-46. PMID 15790537 DOI: 10.1016/j.molbrainres.2004.11.018  0.362
2004 Ding YM, Jaumotte JD, Signore AP, Zigmond MJ. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. Journal of Neurochemistry. 89: 776-87. PMID 15086533 DOI: 10.1111/j.1471-4159.2004.02415.x  0.335
2003 Smith AD, Antion M, Zigmond MJ, Austin MC. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat. Brain Research. Molecular Brain Research. 117: 129-38. PMID 14559146 DOI: 10.1016/S0169-328X(03)00289-4  0.428
2003 Juranyi Z, Zigmond MJ, Harsing LG. [3H]Dopamine release in striatum in response to cortical stimulation in a corticostriatal slice preparation. Journal of Neuroscience Methods. 126: 57-67. PMID 12788502 DOI: 10.1016/S0165-0270(03)00066-9  0.396
2003 Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. Journal of Neurochemistry. 85: 299-305. PMID 12675906 DOI: 10.1046/J.1471-4159.2003.01657.X  0.589
2002 Smith AD, Castro SL, Zigmond MJ. Stress-induced Parkinson's disease: a working hypothesis. Physiology & Behavior. 77: 527-31. PMID 12526994 DOI: 10.1016/S0031-9384(02)00939-3  0.314
2002 Zigmond MJ, Hastings TG, Perez RG. Increased dopamine turnover after partial loss of dopaminergic neurons: compensation or toxicity? Parkinsonism & Related Disorders. 8: 389-93. PMID 12217625 DOI: 10.1016/S1353-8020(02)00019-6  0.326
2002 Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert T, Miller GW. Forced nonuse in unilateral parkinsonian rats exacerbates injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6790-9. PMID 12151559 DOI: 10.1523/Jneurosci.22-15-06790.2002  0.593
2002 Smith AD, Amalric M, Koob GF, Zigmond MJ. Effect of bilateral 6-hydroxydopamine lesions of the medial forebrain bundle on reaction time. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 756-64. PMID 12007746 DOI: 10.1016/S0893-133X(01)00420-1  0.359
2001 Tillerson JL, Cohen AD, Philhower J, Miller GW, Zigmond MJ, Schallert T. Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4427-35. PMID 11404429 DOI: 10.1523/Jneurosci.21-12-04427.2001  0.594
2001 Castro SL, Zigmond MJ. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra. Brain Research. 901: 47-54. PMID 11368949 DOI: 10.1016/S0006-8993(01)02229-6  0.463
2001 Kulagina NV, Zigmond MJ, Michael AC. Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience. 102: 121-8. PMID 11226675 DOI: 10.1016/S0306-4522(00)00480-2  0.438
2000 Chang MS, Sved AF, Zigmond MJ, Austin MC. Increased transcription of the tyrosine hydroxylase gene in individual locus coeruleus neurons following footshock stress. Neuroscience. 101: 131-9. PMID 11068142 DOI: 10.1016/S0306-4522(00)00352-3  0.506
2000 Pearl SM, Antion MD, Stanwood GD, Jaumotte JD, Kapatos G, Zigmond MJ. Effects of NADH on dopamine release in rat striatum. Synapse (New York, N.Y.). 36: 95-101. PMID 10767056 DOI: 10.1002/(Sici)1098-2396(200005)36:2<95::Aid-Syn2>3.0.Co;2-U  0.721
2000 Wu Y, Pearl SM, Zigmond MJ, Michael AC. Inhibitory glutamatergic regulation of evoked dopamine release in striatum. Neuroscience. 96: 65-72. PMID 10683411 DOI: 10.1016/S0306-4522(99)00539-4  0.405
2000 Chang MS, Hahn MK, Sved AF, Zigmond MJ, Austin MC, Sherman TG. Analysis of tyrosine hydroxylase gene transcription using an intron specific probe. Journal of Neuroscience Methods. 94: 177-85. PMID 10661837 DOI: 10.1016/S0165-0270(99)00137-5  0.483
1999 Jedema HP, Sved AF, Zigmond MJ, Finlay JM. Sensitization of norepinephrine release in medial prefrontal cortex: effect of different chronic stress protocols. Brain Research. 830: 211-7. PMID 10366677 DOI: 10.1016/S0006-8993(99)01369-4  0.517
1998 Zigmond MJ, Castro SL, Keefe KA, Abercrombie ED, Sved AF. Role of excitatory amino acids in the regulation of dopamine synthesis and release in the neostriatum. Amino Acids. 14: 57-62. PMID 9871442 DOI: 10.1007/Bf01345243  0.816
1997 Zigmond MJ. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiology of Disease. 4: 247-53. PMID 9361301 DOI: 10.1006/nbdi.1997.0157  0.316
1997 Finlay JM, Zigmond MJ. The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochemical Research. 22: 1387-94. PMID 9355111 DOI: 10.1023/A:1022075324164  0.441
1997 Hastings TG, Zigmond MJ. Loss of dopaminergic neurons in parkinsonism: possible role of reactive dopamine metabolites. Journal of Neural Transmission. Supplementum. 49: 103-10. PMID 9266419  0.374
1997 Finlay JM, Jedema HP, Rabinovic AD, Mana MJ, Zigmond MJ, Sved AF. Impact of corticotropin-releasing hormone on extracellular norepinephrine in prefrontal cortex after chronic cold stress. Journal of Neurochemistry. 69: 144-50. PMID 9202305 DOI: 10.1046/J.1471-4159.1997.69010144.X  0.568
1997 King D, Zigmond MJ, Finlay JM. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 77: 141-53. PMID 9044382 DOI: 10.1016/S0306-4522(96)00421-6  0.468
1996 Harsing LG, Zigmond MJ. Dopaminergic inhibition of striatal GABA release after 6-hydroxydopamine. Brain Research. 738: 142-5. PMID 8949937 DOI: 10.1016/0006-8993(96)00956-0  0.356
1996 Berman SB, Zigmond MJ, Hastings TG. Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. Journal of Neurochemistry. 67: 593-600. PMID 8764584  0.398
1996 Hastings TG, Lewis DA, Zigmond MJ. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proceedings of the National Academy of Sciences of the United States of America. 93: 1956-61. PMID 8700866 DOI: 10.1073/Pnas.93.5.1956  0.428
1996 Castro SL, Sved AF, Zigmond MJ. Increased neostriatal tyrosine hydroxylation during stress: role of extracellular dopamine and excitatory amino acids. Journal of Neurochemistry. 66: 824-33. PMID 8592158  0.623
1995 Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. Journal of Neurochemistry. 65: 111-6. PMID 7790854 DOI: 10.1046/j.1471-4159.1995.65010111.x  0.615
1995 Finlay JM, Zigmond MJ, Abercrombie ED. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 64: 619-28. PMID 7715775 DOI: 10.1016/0306-4522(94)00331-X  0.73
1994 Hastings TG, Zigmond MJ. Identification of catechol-protein conjugates in neostriatal slices incubated with [3H]dopamine: impact of ascorbic acid and glutathione. Journal of Neurochemistry. 63: 1126-32. PMID 8051554 DOI: 10.1046/j.1471-4159.1994.63031126.x  0.385
1994 Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. Journal of Neurochemistry. 63: 575-83. PMID 8035182 DOI: 10.1046/j.1471-4159.1994.63020575.x  0.627
1993 Jackson D, Abercrombie ED, Zigmond MJ. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine. The Journal of Pharmacology and Experimental Therapeutics. 267: 912-8. PMID 8246167  0.68
1993 Keefe KA, Zigmond MJ, Abercrombie ED. In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids. Journal of Neural Transmission. General Section. 91: 223-40. PMID 8099798 DOI: 10.1007/Bf01245233  0.791
1993 Keefe KA, Sved AF, Zigmond MJ, Abercrombie ED. Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids. Journal of Neurochemistry. 61: 1943-52. PMID 7901337 DOI: 10.1111/J.1471-4159.1993.Tb09837.X  0.828
1992 Zigmond MJ, Hastings TG, Abercrombie ED. Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease. Annals of the New York Academy of Sciences. 648: 71-86. PMID 1637074 DOI: 10.1111/j.1749-6632.1992.tb24525.x  0.596
1992 Keefe KA, Zigmond MJ, Abercrombie ED. Extracellular dopamine in striatum: influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input. Neuroscience. 47: 325-32. PMID 1353620 DOI: 10.1016/0306-4522(92)90248-Z  0.792
1992 ABERCROMBIE ED, ZIGMOND MJ. 6-HYDROXYDOPAMINE INDUCED MOTOR DYSFUNCTION Behavioural Pharmacology. 3: 25. DOI: 10.1097/00008877-199204001-00071  0.568
1991 Calne DB, Zigmond MJ. Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism. Archives of Neurology. 48: 361-3. PMID 2012508 DOI: 10.1001/archneur.1991.00530160025009  0.405
1991 Nisenbaum LK, Zigmond MJ, Sved AF, Abercrombie ED. Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 11: 1478-84. PMID 1674004  0.735
1991 Lonart G, Zigmond MJ. High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. The Journal of Pharmacology and Experimental Therapeutics. 256: 1132-8. PMID 1672376  0.371
1990 Zigmond MJ, Abercrombie ED, Stricker EM. Partial damage to nigrostriatal bundle: compensatory changes and the action of L-dopa. Journal of Neural Transmission. Supplementum. 29: 217-32. PMID 2193107 DOI: 10.1007/978-3-7091-9050-0_21  0.747
1990 Lewis RM, Levari I, Ihrig B, Zigmond MJ. In vivo stimulation of D1 receptors increases the phosphorylation of proteins in the striatum. Journal of Neurochemistry. 55: 1071-4. PMID 2166772 DOI: 10.1111/j.1471-4159.1990.tb04600.x  0.337
1990 Salamone JD, Zigmond MJ, Stricker EM. Characterization of the impaired feeding behavior in rats given haloperidol or dopamine-depleting brain lesions. Neuroscience. 39: 17-24. PMID 2128534 DOI: 10.1016/0306-4522(90)90218-S  0.711
1990 Keefe KA, Stricker EM, Zigmond MJ, Abercrombie ED. Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies. Brain Research. 527: 350-3. PMID 2123730 DOI: 10.1016/0006-8993(90)91158-D  0.832
1990 Abercrombie ED, Bonatz AE, Zigmond MJ. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Research. 525: 36-44. PMID 2123121 DOI: 10.1016/0006-8993(90)91318-B  0.718
1990 Onn SP, Balzer JR, Sidney JP, Stricker EM, Zigmond MJ, Berger TW. Lesions of the dopaminergic nigrostriatal system in neonatal rats: effects on the electrophysiological activity of striatal neurons recorded during adulthood. Brain Research. 518: 274-8. PMID 2117988 DOI: 10.1016/0006-8993(90)90980-P  0.641
1990 Snyder GL, Keller RW, Zigmond MJ. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. The Journal of Pharmacology and Experimental Therapeutics. 253: 867-76. PMID 2110978  0.427
1990 Snyder GL, Zigmond MJ. The effects of L-dopa on in vitro dopamine release from striatum. Brain Research. 508: 181-7. PMID 2106362 DOI: 10.1016/0006-8993(90)90394-Q  0.366
1990 Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends in Neurosciences. 13: 290-6. PMID 1695406 DOI: 10.1016/0166-2236(90)90112-N  0.76
1990 Baruchin A, Weisberg EP, Miner LL, Ennis D, Nisenbaum LK, Naylor E, Stricker EM, Zigmond MJ, Kaplan BB. Effects of cold exposure on rat adrenal tyrosine hydroxylase: an analysis of RNA, protein, enzyme activity, and cofactor levels. Journal of Neurochemistry. 54: 1769-75. PMID 1691281 DOI: 10.1111/J.1471-4159.1990.Tb01232.X  0.476
1990 Lonart G, Zigmond MJ. L-glutamic acid evokes Ca2+-independent release of dopamine from rat striatum via dopamine uptake system Annals of the New York Academy of Sciences. 604: 626-628. DOI: 10.1111/J.1749-6632.1990.Tb32045.X  0.414
1990 Keefe KA, Zigmond MJ, Abercrombie ED. Excitatory amino acid receptor involvement in the regulation of striatal extracellular dopamine Annals of the New York Academy of Sciences. 604: 614-616. DOI: 10.1111/J.1749-6632.1990.Tb32042.X  0.769
1990 Jackson D, Zigmond MJ. Regulation of striatal acetylcholine release by dopamine after nigrostriatal bundle injury Annals of the New York Academy of Sciences. 604: 606-608. DOI: 10.1111/j.1749-6632.1990.tb32039.x  0.347
1990 Bernath S, Zigmond MJ. Effects of endogenously released dopamine on [3H]γ-aminobutyric acid efflux from rat striatal slices Annals of the New York Academy of Sciences. 604: 590-591. DOI: 10.1111/j.1749-6632.1990.tb32033.x  0.407
1990 Abercrombie ED, Zigmond MJ. Striatal dopamine release: In vivo evidence for local initiation Annals of the New York Academy of Sciences. 604: 575-578. DOI: 10.1111/j.1749-6632.1990.tb32029.x  0.703
1990 Zigmond MJ, Keefe KA, Stricker EM, Abercrombie ED. Compensations in an animal model of Parkinsonism: implications for behavior under basal conditions and in response to stress European Journal of Pharmacology. 183: 612-613. DOI: 10.1016/0014-2999(90)93534-W  0.764
1990 Abercrombie ED, Castro SL, Zigmond MJ. In vivo evidence that dopamine formed from exogenous L-DOPA in striatum is released in an impulse-independent manner European Journal of Pharmacology. 183: 415-416. DOI: 10.1016/0014-2999(90)93298-5  0.696
1989 Salamone JD, Keller RW, Zigmond MJ, Stricker EM. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion. Brain Research. 487: 215-24. PMID 2786443 DOI: 10.1016/0006-8993(89)90826-3  0.722
1989 Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. Journal of Neurochemistry. 52: 1655-8. PMID 2709017 DOI: 10.1111/J.1471-4159.1989.Tb09224.X  0.796
1989 Zigmond MJ, Stricker EM. Animal models of parkinsonism using selective neurotoxins: clinical and basic implications. International Review of Neurobiology. 31: 1-79. PMID 2689379 DOI: 10.1016/S0074-7742(08)60277-9  0.559
1989 Bernath S, Zigmond MJ. Dopamine may influence striatal GABA release via three separate mechanisms. Brain Research. 476: 373-6. PMID 2649207 DOI: 10.1016/0006-8993(89)91262-6  0.346
1989 Weisberg EP, Baruchin A, Stachowiak MK, Stricker EM, Zigmond MJ, Kaplan BB. Isolation of a rat adrenal cDNA clone encoding phenylethanolamine N-methyltransferase and cold-induced alterations in adrenal PNMT mRNA and protein. Brain Research. Molecular Brain Research. 6: 159-66. PMID 2575695 DOI: 10.1016/0169-328X(89)90050-8  0.51
1989 Carder RK, Jackson D, Morris HJ, Lund RD, Zigmond MJ. Dopamine released from mesencephalic transplants restores modulation of striatal acetylcholine release after neonatal 6-hydroxydopamine: an in vitro analysis. Experimental Neurology. 105: 251-9. PMID 2569987 DOI: 10.1016/0014-4886(89)90127-1  0.452
1989 Wolf ME, Zigmond MJ, Kapatos G. Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study. Journal of Neurochemistry. 53: 879-85. PMID 2569507 DOI: 10.1111/J.1471-4159.1989.Tb11786.X  0.465
1989 Abercrombie ED, Zigmond MJ. Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 4062-7. PMID 2511282  0.657
1989 MacKenzie RG, Stachowiak MK, Zigmond MJ. Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine. European Journal of Pharmacology. 168: 43-52. PMID 2511032 DOI: 10.1016/0014-2999(89)90631-6  0.424
1989 Keefe KA, Salamone JD, Zigmond MJ, Stricker EM. Paradoxical kinesia in parkinsonism is not caused by dopamine release. Studies in an animal model. Archives of Neurology. 46: 1070-5. PMID 2508609 DOI: 10.1001/Archneur.1989.00520460046012  0.818
1989 Zigmond MJ, Berger TW, Grace AA, Stricker EM. Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 10: 185-200. PMID 2504173 DOI: 10.1007/Bf03159728  0.669
1988 Keller RW, Kuhr WG, Wightman RM, Zigmond MJ. The effect of L-dopa on in vivo dopamine release from nigrostriatal bundle neurons. Brain Research. 447: 191-4. PMID 3382951 DOI: 10.1016/0006-8993(88)90985-7  0.383
1988 Abercrombie ED, Keller RW, Zigmond MJ. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience. 27: 897-904. PMID 3252176 DOI: 10.1016/0306-4522(88)90192-3  0.685
1988 Jackson D, Stachowiak MK, Bruno JP, Zigmond MJ. Inhibition of striatal acetylcholine release by endogenous serotonin. Brain Research. 457: 259-66. PMID 3219554 DOI: 10.1016/0006-8993(88)90694-4  0.543
1988 Nisenbaum ES, Stricker EM, Zigmond MJ, Berger TW. Spontaneous activity of type II but not type I striatal neurons is correlated with recovery of behavioral function after dopamine-depleting brain lesions. Brain Research. 473: 389-93. PMID 3148358 DOI: 10.1016/0006-8993(88)90872-4  0.588
1988 Jackson D, Bruno JP, Stachowiak MK, Zigmond MJ. Inhibition of striatal acetylcholine release by serotonin and dopamine after the intracerebral administration of 6-hydroxydopamine to neonatal rats. Brain Research. 457: 267-73. PMID 3146404 DOI: 10.1016/0006-8993(88)90695-6  0.668
1988 Stachowiak M, Stricker EM, Zigmond MJ, Kaplan BB. A cholinergic antagonist blocks cold stress-induced alterations in rat adrenal tyrosine hydroxylase mRNA. Brain Research. 427: 193-5. PMID 2898270 DOI: 10.1016/0169-328X(88)90066-6  0.501
1987 Orr WB, Stricker EM, Zigmond MJ, Berger TW. Effects of dopamine depletion on the spontaneous activity of type I striatal neurons: relation to local dopamine concentration and motor behavior. Synapse (New York, N.Y.). 1: 461-9. PMID 3145581 DOI: 10.1002/Syn.890010510  0.601
1987 Stachowiak MK, Keller RW, Stricker EM, Zigmond MJ. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 1648-54. PMID 3110381 DOI: 10.1523/Jneurosci.07-06-01648.1987  0.684
1987 Fluharty SJ, Vollmer RR, Meyers SA, McCann MJ, Zigmond MJ, Stricker EM. Recovery of chronotropic responsiveness after systemic 6-hydroxydopamine treatment: studies in the pithed rat. The Journal of Pharmacology and Experimental Therapeutics. 243: 415-23. PMID 2890754  0.544
1987 Bruno JP, Jackson D, Zigmond MJ, Stricker EM. Effect of dopamine-depleting brain lesions in rat pups: role of striatal serotonergic neurons in behavior. Behavioral Neuroscience. 101: 806-11. PMID 2447910 DOI: 10.1037//0735-7044.101.6.806  0.726
1987 Stachowiak M, Keller R, Stricker E, Zigmond M. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage The Journal of Neuroscience. 7: 1648-1654. DOI: 10.1523/JNEUROSCI.07-06-01648.1987  0.624
1986 Nisenbaum ES, Stricker EM, Zigmond MJ, Berger TW. Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery. Brain Research. 398: 221-30. PMID 3099976 DOI: 10.1016/0006-8993(86)91481-2  0.63
1986 Onn SP, Berger TW, Stricker EM, Zigmond MJ. Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Research. 376: 8-19. PMID 3087584 DOI: 10.1016/0006-8993(86)90894-2  0.633
1986 Orr WB, Gardiner TW, Stricker EM, Zigmond MJ, Berger TW. Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior. Brain Research. 376: 20-8. PMID 3087583 DOI: 10.1016/0006-8993(86)90895-4  0.645
1986 Bruno JP, Zigmond MJ, Stricker EM. Rats given dopamine-depleting brain lesions as neonates do not respond to acute homeostatic imbalances as adults. Behavioral Neuroscience. 100: 125-8. PMID 3082343 DOI: 10.1037//0735-7044.100.1.125  0.743
1986 Stachowiak MK, Fluharty SJ, Stricker EM, Zigmond MJ, Kaplan BB. Molecular adaptations in catecholamine biosynthesis induced by cold stress and sympathectomy. Journal of Neuroscience Research. 16: 13-24. PMID 2427735 DOI: 10.1002/Jnr.490160104  0.502
1986 Stachowiak MK, Stricker EM, Jacoby JH, Zigmond MJ. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine. Biochemical Pharmacology. 35: 1241-8. PMID 2421731 DOI: 10.1016/0006-2952(86)90266-2  0.463
1986 Snyder AM, Zigmond MJ, Lund RD. Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. The Journal of Comparative Neurology. 245: 274-81. PMID 2420842 DOI: 10.1002/cne.902450209  0.362
1985 Bruno JP, Stricker EM, Zigmond MJ. Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behavioral Neuroscience. 99: 771-5. PMID 3939667 DOI: 10.1037//0735-7044.99.4.771  0.749
1985 Snyder AM, Stricker EM, Zigmond MJ. Stress-induced neurological impairments in an animal model of parkinsonism. Annals of Neurology. 18: 544-51. PMID 3935041 DOI: 10.1002/Ana.410180506  0.637
1985 Berger TW, Kaul S, Stricker EM, Zigmond MJ. Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Research. 336: 354-8. PMID 3924346 DOI: 10.1016/0006-8993(85)90667-5  0.616
1985 Stachowiak M, Sebbane R, Stricker EM, Zigmond MJ, Kaplan BB. Effect of chronic cold exposure on tyrosine hydroxylase mRNA in rat adrenal gland. Brain Research. 359: 356-9. PMID 2866819 DOI: 10.1016/0006-8993(85)91450-7  0.504
1985 Fluharty SJ, Rabow LE, Zigmond MJ, Stricker EM. Tyrosine hydroxylase activity in the sympathoadrenal system under basal and stressful conditions: effect of 6-hydroxydopamine. The Journal of Pharmacology and Experimental Therapeutics. 235: 354-60. PMID 2865349  0.51
1985 Fluharty SJ, Snyder GL, Zigmond MJ, Stricker EM. Tyrosine hydroxylase activity and catecholamine biosynthesis in the adrenal medulla of rats during stress. The Journal of Pharmacology and Experimental Therapeutics. 233: 32-8. PMID 2858582  0.526
1985 Granneman JG, MacKenzie RG, Fluharty SJ, Zigmond MJ, Stricker EM. Neural control of adenylate cyclase responsiveness in brown adipose tissue. The Journal of Pharmacology and Experimental Therapeutics. 233: 163-7. PMID 2858577  0.473
1984 Stricker EM, Zigmond MJ. Brain catecholamines and the central control of food intake. International Journal of Obesity. 8: 39-50. PMID 6398807  0.558
1984 Stachowiak MK, Bruno JP, Snyder AM, Stricker EM, Zigmond MJ. Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Research. 291: 164-7. PMID 6199080 DOI: 10.1016/0006-8993(84)90665-6  0.728
1984 Fluharty SJ, Stricker EM, Zigmond MJ. Partial damage to the noradrenergic bundle increases tyrosine hydroxylase activity in noradrenergic terminals of hippocampus but not cerebellum. Brain Research. 324: 390-3. PMID 6152190 DOI: 10.1016/0006-8993(84)90056-8  0.542
1984 Zigmond MJ, Acheson AL, Stachowiak MK, Stricker EM. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Archives of Neurology. 41: 856-61. PMID 6147127 DOI: 10.1001/archneur.1984.04050190062015  0.646
1984 Zigmond MJ, Stricker EM. Parkinson's disease: studies with an animal model. Life Sciences. 35: 5-18. PMID 6146085 DOI: 10.1016/0024-3205(84)90147-4  0.632
1984 Stricker E, Zigmond M. Comment on Effects of Nigrostriatal Dopamine Lesions Appetite. 5: 266-267. DOI: 10.1016/S0195-6663(84)80021-5  0.59
1983 Keller RW, Stricker EM, Zigmond MJ. Environmental stimuli but not homeostatic challenges produce apparent increases in dopaminergic activity in the striatum: an analysis by in vivo voltammetry. Brain Research. 279: 159-70. PMID 6640335 DOI: 10.1016/0006-8993(83)90174-9  0.54
1983 Fluharty SJ, Snyder GL, Stricker EM, Zigmond MJ. Short- and long-term changes in adrenal tyrosine hydroxylase activity during insulin-induced hypoglycemia and cold stress. Brain Research. 267: 384-7. PMID 6135493 DOI: 10.1016/0006-8993(83)90895-8  0.486
1983 Chiodo LA, Acheson AL, Zigmond MJ, Stricker EM. Subtotal destruction of central noradrenergic projections increases the firing rate of locus coeruleus cells. Brain Research. 264: 123-6. PMID 6133579 DOI: 10.1016/0006-8993(83)91128-9  0.555
1983 Bruno J, Stachowiak M, Snyder A, Onn S, Stricker E, Zigmond M. Sprouting of striatal neurons following neonatal 6-hydroxydopamine International Journal of Developmental Neuroscience. 1: 228-228. DOI: 10.1016/0736-5748(83)90320-9  0.563
1982 Kapatos G, Zigmond MJ. Influence of calcium on dopamine synthesis and tyrosine hydroxylase activity in rat striatum. Journal of Neurochemistry. 39: 327-35. PMID 6123555  0.387
1981 Sherman KA, Zigmond MJ, Hanin I. Fluphenazine-induced decline in striatal acetylcholine content is not abolished by exogenous choline. Neuropharmacology. 20: 921-4. PMID 7301054 DOI: 10.1016/0028-3908(81)90021-6  0.31
1980 Zigmond MJ, Stricker EM. Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion. Experientia. 36: 436-8. PMID 7379917 DOI: 10.1007/BF01975133  0.662
1980 Zigmond MJ, Heffner TG, Stricker EM. The effect of altered dopaminergic activity on food intake in the rat: evidence for an optimal level of dopaminergic activity for behavior. Progress in Neuro-Psychopharmacology. 4: 351-62. PMID 7220661 DOI: 10.1016/0364-7722(80)90005-3  0.594
1980 Acheson AL, Zigmond MJ, Stricker EM. Compensatory increase in tyrosine hydroxylase activity in rat brain after intraventricular injections of 6-hydroxydopamine. Science (New York, N.Y.). 207: 537-40. PMID 6101509 DOI: 10.1126/Science.6101509  0.547
1979 Stricker EM, Cooper PH, Marshall JF, Zigmond MJ. Acute homeostatic imbalances reinstate sensorimotor dysfunctions in rats with lateral hypothalamic lesions. Journal of Comparative and Physiological Psychology. 93: 512-21. PMID 573287 DOI: 10.1037/H0077591  0.558
1979 Kapatos G, Zigmond MJ. Regulation of dopamine synthesis in striatal synaptosomes during depolarization. Brain Research. 170: 299-312. PMID 37985 DOI: 10.1016/0006-8993(79)90108-2  0.42
1979 Kapatos G, Zigmond MJ. Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes. The Journal of Pharmacology and Experimental Therapeutics. 208: 468-75. PMID 34711  0.415
1978 Stricker EM, Swerdloff AF, Zigmond MJ. Intrahypothalamic injections of kainic acid produce feeding and drinking deficits in rats. Brain Research. 158: 470-3. PMID 709378 DOI: 10.1016/0006-8993(78)90692-3  0.502
1977 Stricker EM, Zimmerman MB, Friedman MI, Zigmond MJ. Caffeine restores feeding response to 2-deoxy-D-glucose in 6-hydroxydopamine-treated rats. Nature. 267: 174-5. PMID 16073437 DOI: 10.1038/267174A0  0.549
1977 Heffner TG, Zigmond MJ, Stricker EM. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats. The Journal of Pharmacology and Experimental Therapeutics. 201: 386-99. PMID 859104  0.621
1977 Kapatos G, Zigmond M. Dopamine biosynthesis from L-tyrosine and L-phenylalanine in rat brain synaptosomes: preferential use of newly accumulated precursors. Journal of Neurochemistry. 28: 1109-19. PMID 16989 DOI: 10.1111/J.1471-4159.1977.Tb10675.X  0.443
1975 Stricker EM, Rowland N, Zigmond MJ. Trigeminal lemniscal lesions and the lateral hypothalamic syndrome. Science (New York, N.Y.). 190: 694-6. PMID 1188367 DOI: 10.1126/Science.1188367  0.435
1975 Stricker EM, Friedman MI, Zigmond MJ. Glucoregulatory feeding by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science (New York, N.Y.). 189: 895-7. PMID 1154028 DOI: 10.1126/Science.1154028  0.535
1974 Stricker EM, Zigmond MJ. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats. Journal of Comparative and Physiological Psychology. 86: 973-94. PMID 4836848 DOI: 10.1037/H0037638  0.507
1974 Zigmond MJ, Stricker EM. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function. Advances in Biochemical Psychopharmacology. 12: 385-402. PMID 4609140  0.578
1974 Zigmond MJ, Stricker EM. Proceedings: The effects on ingestive behaviors of damage to central dopamine-containing neurons. Psychopharmacology Bulletin. 10: 40-1. PMID 4419472  0.587
1973 Zigmond MJ, Stricker EM. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. Science (New York, N.Y.). 182: 717-20. PMID 4752211 DOI: 10.1126/Science.182.4113.717  0.555
1972 Zigmond MJ, Stricker EM. Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science (New York, N.Y.). 177: 1211-4. PMID 5057630 DOI: 10.1126/Science.177.4055.1211  0.608
1969 Pohorecky LA, Zigmond M, Karten H, Wurtman RJ. Enzymatic conversion of norepinephrine to epinephrine by the brain. The Journal of Pharmacology and Experimental Therapeutics. 165: 190-5. PMID 5763055  0.509
1969 Pohorecky LA, Zigmond MJ, Heimer L, Wurtman RJ. Olfactory bulb removal: effects on brain norepinephrine. Proceedings of the National Academy of Sciences of the United States of America. 62: 1052-5. PMID 5256405 DOI: 10.1073/pnas.62.4.1052  0.634
1969 Zigmond MJ, Shoemaker WJ, Larin F, Wurtman RJ. Hepatic tyrosine transaminase rhythm: interaction of environmental lighting, food consumption and dietary protein content. The Journal of Nutrition. 98: 71-5. PMID 4389949 DOI: 10.1093/Jn/98.1.71  0.343
1968 Wurtman RJ, Zigmond MJ. Pharmacologic tools in autonomic nervous system research. Anesthesiology. 29: 714-23. PMID 4874156 DOI: 10.1097/00000542-196807000-00016  0.358
1968 Wurtman RJ, Shoemaker WJ, Larin F, Zigmond M. Failure of brain norepinephrine depletion to extinguish the daily rhythm in hepatic tyrosine transaminase activity. Nature. 219: 1049-50. PMID 4386260 DOI: 10.1038/2191049A0  0.391
Low-probability matches (unlikely to be authored by this person)
2021 Jaumotte JD, Saarma M, Zigmond MJ. Protection of dopamine neurons by CDNF and neurturin variant N4 against MPP+ in dissociated cultures from rat mesencephalon. Plos One. 16: e0245663. PMID 33534843 DOI: 10.1371/journal.pone.0245663  0.297
2003 Smith AD, Zigmond MJ. Can the brain be protected through exercise? Lessons from an animal model of parkinsonism. Experimental Neurology. 184: 31-9. PMID 14637076 DOI: 10.1016/j.expneurol.2003.08.017  0.292
2002 Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ. A Role for α-Synuclein in the Regulation of Dopamine Biosynthesis The Journal of Neuroscience. 22: 3090-3099. DOI: 10.1523/JNEUROSCI.22-08-03090.2002  0.287
2000 Smith AD, Smith DL, Zigmond MJ, Amalric M, Koob GF. Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm. Psychopharmacology. 148: 355-60. PMID 10928307 DOI: 10.1007/s002130050063  0.287
2016 Jaumotte JD, Wyrostek SL, Zigmond MJ. Protection of Cultured Dopamine Neurons from MPP(+) Requires a Combination of Neurotrophic Factors. The European Journal of Neuroscience. PMID 27098376 DOI: 10.1111/ejn.13252  0.286
2006 Cavanaugh JE, Jaumotte JD, Lakoski JM, Zigmond MJ. Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. Journal of Neuroscience Research. 84: 1367-75. PMID 16941494 DOI: 10.1002/jnr.21024  0.283
2010 Lopresti BJ, Dettmar A, Leak R, Rockcastle NJ, Zigmond MJ, Mathis C, Zhang Z, Cameron J. Regular exercise training protects against MPTP-damage to nigrostriatal dopamine neurons in nonhuman primates Neuroimage. 52: S66. DOI: 10.1016/J.Neuroimage.2010.04.051  0.282
1997 Harsing LG, Zigmond MJ. Influence of dopamine on GABA release in striatum: evidence for D1-D2 interactions and non-synaptic influences. Neuroscience. 77: 419-29. PMID 9472401 DOI: 10.1016/S0306-4522(96)00475-7  0.275
2002 Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ. A role for alpha-synuclein in the regulation of dopamine biosynthesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3090-9. PMID 11943812  0.266
2014 Parmar MS, Jaumotte JD, Wyrostek SL, Zigmond MJ, Cavanaugh JE. Role of ERK1, 2, and 5 in dopamine neuron survival during aging. Neurobiology of Aging. 35: 669-79. PMID 24411019 DOI: 10.1016/J.Neurobiolaging.2013.09.031  0.265
1985 MacKenzie RG, Zigmond MJ. Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum. European Journal of Pharmacology. 113: 159-65. PMID 2864265 DOI: 10.1016/0014-2999(85)90732-0  0.26
1983 Mantione CR, Zigmond MJ, Fisher A, Hanin I. Selective presynaptic cholinergic neurotoxicity following intrahippocampal AF64A injection in rats. Journal of Neurochemistry. 41: 251-5. PMID 6688090  0.259
2006 Lopresti B, Venneti S, Wang G, Mason NS, Mathis CA, Slagel S, Hastings T, Smith A, Suhara T, Zigmond M, Wiley C. The high-affinity peripheral benzodiazepine receptor ligand [C-11]DAA1106 results in improved delineation of neuroinflammatory lesions in a rodent model of disease compared to [C-11]PK11195 Neuroimage. 31. DOI: 10.1016/J.Neuroimage.2006.04.118  0.252
2011 Allen E, Carlson KM, Zigmond MJ, Cavanaugh JE. L-DOPA reverses motor deficits associated with normal aging in mice. Neuroscience Letters. 489: 1-4. PMID 21111775 DOI: 10.1016/j.neulet.2010.11.054  0.252
2006 Leak RK, Liou AK, Zigmond MJ. Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning. Journal of Neurochemistry. 99: 1151-63. PMID 16956375 DOI: 10.1111/j.1471-4159.2006.04149.x  0.251
1991 Lonart G, Zigmond MJ. Incubation of tissue slices in the absence of Ca2+ and Mg2+ can cause nonspecific damage. Journal of Neurochemistry. 56: 1445-8. PMID 1672150 DOI: 10.1111/J.1471-4159.1991.Tb11445.X  0.25
2010 Allen E, Carlson K, Zigmond M, Cavanaugh J. 035 L-Dopa Reverses Motor Deficits Associated With Normal Aging In Mice Parkinsonism & Related Disorders. 16. DOI: 10.1016/S1353-8020(10)70036-5  0.246
1998 Zigmond MJ, Hastings TG. Neurochemical responses to lesions of dopaminergic neurons: implications for compensation and neuropathology. Advances in Pharmacology (San Diego, Calif.). 42: 788-92. PMID 9328016 DOI: 10.1016/S1054-3589(08)60865-0  0.245
2007 Stein DJ, Collins M, Daniels W, Noakes TD, Zigmond M. Mind and muscle: the cognitive-affective neuroscience of exercise. Cns Spectrums. 12: 19-22. PMID 17192760 DOI: 10.1017/S1092852900020484  0.245
1996 Hastings TG, Lewis DA, Zigmond MJ. Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Advances in Experimental Medicine and Biology. 387: 97-106. PMID 8794199 DOI: 10.1007/978-1-4757-9480-9_13  0.242
1978 Sherman KA, Zigmond MJ, Hanin I. High affinity choline uptake in striatum and hippocampus: differential effects of treatments which release acetylcholine. Life Sciences. 23: 1863-70. PMID 723454  0.239
1990 Bernath S, Zigmond MJ. Dopamine enhances striatal GABA release via an influence on the GABA uptake system Biogenic Amines. 7: 465-473.  0.233
2003 Ugarte SD, Lin E, Klann E, Zigmond MJ, Perez RG. Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. Journal of Neuroscience Research. 73: 105-12. PMID 12815714 DOI: 10.1002/jnr.10632  0.232
1981 Acheson AL, Zigmond MJ. Short and long term changes in tyrosine hydroxylase activity in rat brain after subtotal destruction of central noradrenergic neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 1: 493-504. PMID 6125573  0.232
1973 Caggiula AR, Antelman SM, Zigmond MJ. Disruption of copulation in male rats after hypothalamic lesions: a behavioral, anatomical and neurochemical analysis. Brain Research. 59: 273-87. PMID 4747756  0.221
1974 Caggiula AR, Antelman SM, Zigmond MJ. Ineffectiveness of sexually arousing stimulation after hypothalamic lesions in the rat. Physiology & Behavior. 12: 313-6. PMID 4593163 DOI: 10.1016/0031-9384(74)90191-7  0.211
1971 Zigmond MJ, Chalmers JP, Simpson JR, Wurtman RJ. Effect of lateral hypothalamic lesions on uptake of norepinephrine by brain homogenates. The Journal of Pharmacology and Experimental Therapeutics. 179: 20-8. PMID 4938136  0.205
1984 MacKenzie RG, Zigmond MJ. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment. Journal of Neurochemistry. 43: 1310-8. PMID 6208330  0.202
1993 Robinson GB, Fluharty SJ, Zigmond MJ, Sclabassi RJ, Berger TW. Recovery of hippocampal dentate granule cell responsiveness to entorhinal cortical input following norepinephrine depletion. Brain Research. 614: 21-8. PMID 7688646 DOI: 10.1016/0006-8993(93)91013-I  0.198
2008 Lopresti BJ, Zhang Z, Zigmond M, Leak R, Mathis C, Cameron J. Increased survival of nigrostriatal dopaminergic neurons following a toxic MPTP insult in the exercising primate: A [11C]DTBZ PET study Neuroimage. 41: T55. DOI: 10.1016/J.Neuroimage.2008.04.229  0.192
1998 Harsing LG, Zigmond MJ. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Brain Research Bulletin. 45: 607-13. PMID 9566505 DOI: 10.1016/S0361-9230(97)00460-7  0.192
1974 Heffner TG, Drawbaugh RB, Zigmond MJ. Amphetamine and operant behavior in rats: relationship between drug effect and control response rate. Journal of Comparative and Physiological Psychology. 86: 1031-43. PMID 4836852  0.191
1992 Bernath S, Berger T, Zigmond M. Carrier-mediated, non-vesicular release of GABA in the striatum is important to neuronal interactions Neurochemistry International. 21: W2. DOI: 10.1016/0197-0186(92)91866-U  0.188
1978 Sherman KA, Hanin I, Zigmond MJ. The effect of neuroleptics on acetylcholine concentration and choline uptake in striatum: Implications for regulation of acetylcholine metabolism. The Journal of Pharmacology and Experimental Therapeutics. 206: 677-86. PMID 29960  0.188
1984 Mackenzie RG, Zigmond MJ. 3H-cis-(Z)-flupenthixol binding to D1 receptors in rat striatum Federation Proceedings. 43: no. 2.  0.184
2014 Russell VA, Zigmond MJ, Dimatelis JJ, Daniels WM, Mabandla MV. The interaction between stress and exercise, and its impact on brain function. Metabolic Brain Disease. 29: 255-60. PMID 24399497 DOI: 10.1007/s11011-013-9479-y  0.183
1995 Giovanni A, Liang LP, Hastings TG, Zigmond MJ. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. Journal of Neurochemistry. 64: 1819-25. PMID 7891110 DOI: 10.1046/j.1471-4159.1995.64041819.x  0.18
2008 Leak RK, Zigmond MJ, Liou AK. Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism. Journal of Neurochemistry. 106: 860-74. PMID 18466318 DOI: 10.1111/j.1471-4159.2008.05459.x  0.177
1987 Keller RW, Zigmond MJ. Advances in Neurochemistry: Monitoring Neurotransmitter Release during Behavior. Science (New York, N.Y.). 238: 1448-9. PMID 17800580 DOI: 10.1126/science.238.4832.1448  0.174
2008 Lin E, Cavanaugh JE, Leak RK, Perez RG, Zigmond MJ. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. Journal of Neuroscience Research. 86: 108-17. PMID 17847117 DOI: 10.1002/jnr.21478  0.173
1979 Kennedy LA, Zigmond MJ. The behavioral effects of D-amphetamine are correlated with its effects on cAMP in different brain regions. Brain Research. 168: 408-13. PMID 221074 DOI: 10.1016/0006-8993(79)90184-7  0.173
1970 Zigmond MJ, Harvey JA. Resistance to central norepinephrine depletion and decreased mortality in rats chronically exposed to electric foot shock. Journal of Neuro-Visceral Relations. 31: 373-81. PMID 5435531 DOI: 10.1007/BF02312738  0.172
2001 Zigmond M, Epperly M, Sikora C, Perez R, Greenberger J. Dopaminergic neurons are protected from ionizing irradiation and 6-hydroxydopamine-induced apoptosis by overexpression of the Manganese Superoxide Dismutase (MnSOD) transgene International Journal of Radiation Oncology*Biology*Physics. 51: 231. DOI: 10.1016/S0360-3016(01)02244-1  0.171
2009 Daniels WM, Fairbairn LR, van Tilburg G, McEvoy CR, Zigmond MJ, Russell VA, Stein DJ. Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region. Metabolic Brain Disease. 24: 615-27. PMID 19816761 DOI: 10.1007/S11011-009-9163-4  0.171
2010 Smith AD, Michael AC, Lopresti BJ, Narendran R, Zigmond MJ. Monoamines: Release studies Encyclopedia of Neuroscience. 953-960. DOI: 10.1016/B978-008045046-9.01152-9  0.169
2016 Parmar MS, Jaumotte JD, Zigmond MJ, Cavanaugh JE. ERK1, 2, and 5 expression and activation in dopaminergic brain regions during postnatal development International Journal of Developmental Neuroscience. 46: 44-50. DOI: 10.1016/j.ijdevneu.2015.06.009  0.166
2007 Venneti S, Lopresti BJ, Wang G, Slagel SL, Mason NS, Mathis CA, Fischer ML, Larsen NJ, Mortimer AD, Hastings TG, Smith AD, Zigmond MJ, Suhara T, Higuchi M, Wiley CA. A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. Journal of Neurochemistry. 102: 2118-31. PMID 17555551 DOI: 10.1111/J.1471-4159.2007.04690.X  0.163
1984 Roffler-Tarlov S, Landis SC, Zigmond MJ. Effects of Purkinje cell degeneration on the noradrenergic projection to mouse cerebellar cortex. Brain Research. 298: 303-11. PMID 6144362 DOI: 10.1016/0006-8993(84)91429-X  0.162
2014 Stetler RA, Leak RK, Gan Y, Li P, Zhang F, Hu X, Jing Z, Chen J, Zigmond MJ, Gao Y. Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Progress in Neurobiology. 114: 58-83. PMID 24389580 DOI: 10.1016/J.Pneurobio.2013.11.005  0.16
1988 Bernath S, Zigmond MJ. Characterization of [3H]GABA release from striatal slices: evidence for a calcium-independent process via the GABA uptake system. Neuroscience. 27: 563-70. PMID 3217004 DOI: 10.1016/0306-4522(88)90289-8  0.157
2000 Zigmond MJ. When it comes to communications between neurons, synapses are over-rated: insights from an animal model of parkinsonism. Progress in Brain Research. 125: 317-26. PMID 11098668 DOI: 10.1016/S0079-6123(00)25021-8  0.15
1974 Schoenfeld RI, Zigmond MJ. Behavioural pharmacology of 6-hydroxydopamine Biochemical Pharmacology. 23: 568-573. DOI: 10.1016/0006-2952(74)90085-9  0.147
2008 Liou AK, Leak RK, Li L, Zigmond MJ. Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiology of Disease. 32: 116-24. PMID 18675914 DOI: 10.1016/j.nbd.2008.06.016  0.144
1978 Saller CF, Zigmond MJ. A radioenzymatic assay for catecholamines and dihydroxyphenylacetic acid. Life Sciences. 23: 1117-30. PMID 30872  0.136
2012 Mitchell AC, Leak RK, Zigmond MJ, Cameron JL, Mirnics K. Gene transcripts associated with BMI in the motor cortex and caudate nucleus of calorie restricted rhesus monkeys. Genomics. 99: 144-51. PMID 22227022 DOI: 10.1016/J.Ygeno.2011.12.006  0.134
2007 Venneti S, Lopresti BJ, Wang G, Slagel S, Mason NS, Mathis C, Fischer M, Larsen NJ, Mortimer AD, Hastings TG, Smith AD, Zigmond MJ, Suhara T, Higuchi M, Wiley CA. The high-affinity peripheral benzodiazepine receptor ligand [11C]DAA1106 can be used to image microglia in animal models of Parkinson's disease and neuroinflammation in vivo using PET Journal of Neuropathology and Experimental Neurology. 66: 430. DOI: 10.1097/01.Jnen.0000268850.20477.95  0.125
2007 Venneti S, Lopresti BJ, Wang G, Slagel S, Mason NS, Mathis C, Fischer M, Larsen NJ, Mortimer AD, Hastings TG, Smith AD, Zigmond MJ, Suhara T, Higuchi M, Wiley CA. The high‐affinity peripheral benzodiazepine receptor ligand [11C]DAA1106 can be used to image microglia in animal models of Parkinson's disease and neuroinflammation in vivo using PET. The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A29-A  0.124
1973 Schoenfeld R, Zigmond M. Behavioral pharmacology of 6-hydroxydopamine Life Sciences. 13: cxlii-cxliv. DOI: 10.1016/0024-3205(73)90389-5  0.123
1981 Acheson AL, Kapatos G, Zigmond MJ. The effects of phosphorylating conditions on tyrosine hydroxylase activity are influenced by assay conditions and brain region. Life Sciences. 28: 1407-20. PMID 6113525 DOI: 10.1016/0024-3205(81)90416-1  0.117
1989 Bernath S, Keller RW, Zigmond MJ. Release of endogenous GABA can occur through Ca(2+)-dependent and Ca(2+)-independent processes. Neurochemistry International. 14: 439-45. PMID 20504447  0.116
2012 Mitchell AC, Leak RK, Garbett K, Zigmond MJ, Cameron JL, Mirnics K. Physical activity-associated gene expression signature in nonhuman primate motor cortex. Obesity (Silver Spring, Md.). 20: 692-8. PMID 22016091 DOI: 10.1038/Oby.2011.328  0.116
1973 Zigmond MJ, Wilson SP. Studies on the interaction between catecholamines and tyrosine aminotransferase in brain. Biochemical Pharmacology. 22: 2151-63. PMID 4147420  0.115
1984 Fluharty SJ, Rabow LE, Stricker EM, Zigmond MJ. Neurochemical adaptations after partial sympathectomy: Adrenal and cardiac tyrosine hydroxylase activity Federation Proceedings. 43: no. 4303.  0.108
2011 Zhang F, Wang S, Gan L, Vosler PS, Gao Y, Zigmond MJ, Chen J. Protective effects and mechanisms of sirtuins in the nervous system. Progress in Neurobiology. 95: 373-95. PMID 21930182 DOI: 10.1016/j.pneurobio.2011.09.001  0.108
1983 Birdsall NJ, Burgen AS, Hulme EC, Stockton JM, Zigmond MJ. The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. British Journal of Pharmacology. 78: 257-9. PMID 6187403 DOI: 10.1111/J.1476-5381.1983.Tb09388.X  0.104
1970 Zigmond MJ, Wurtman RJ. Daily rhythm in the accumulation of brain catechol-amines synthesized fom circulating H3-tyrosine. The Journal of Pharmacology and Experimental Therapeutics. 172: 416-22. PMID 5459066  0.103
1990 Bernath S, Zigmond MJ. Calcium-independent GABA release from striatal slices: the role of calcium channels. Neuroscience. 36: 677-82. PMID 2172861 DOI: 10.1016/0306-4522(90)90010-2  0.099
2012 Chen J, Liou A, Zhang L, Weng Z, Gao Y, Cao G, Zigmond MJ, Chen J. GST P1, a novel downstream regulator of LRRK2, G2019S-induced neuronal cell death. Frontiers in Bioscience (Elite Edition). 4: 2365-77. PMID 22652643  0.094
1994 Zigmond MJ. Chemical transmission in the brain: homeostatic regulation and its functional implications. Progress in Brain Research. 100: 115-22. PMID 7938509 DOI: 10.1016/S0079-6123(08)60776-1  0.092
2014 Caputo LM, Beyer CE, Neary MP, Zigmond MJ, Castro SL, Bar-Or D. Assessment of Oxidative Stress and Treatment with a Novel Antioxidant Compound in a Mouse Model of Parkinson’s Disease Free Radical Biology and Medicine. 76: S79-S80. DOI: 10.1016/J.FREERADBIOMED.2014.10.282  0.089
1993 Bernath S, Zigmond MJ, Nisenbaum ES, Vizi ES, Berger TW. Na+ influx through Ca2+ channels can promote striatal GABA efflux in Ca(2+)-deficient conditions in response to electrical field depolarization. Brain Research. 632: 232-8. PMID 8149231 DOI: 10.1016/0006-8993(93)91158-O  0.081
1983 Birdsall NJ, Hulme EC, Stockton J, Burgen AS, Berrie CP, Hammer R, Wong EH, Zigmond MJ. Muscarinic receptor subclasses: evidence from binding studies. Advances in Biochemical Psychopharmacology. 37: 323-9. PMID 6688916  0.072
1999 Zigmond MJ. Otto Loewi and the demonstration of chemical neurotransmission. Brain Research Bulletin. 50: 347-8. PMID 10643430 DOI: 10.1016/S0361-9230(99)00099-4  0.067
1999 Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96: 857-68. PMID 10102273 DOI: 10.1016/S0092-8674(00)80595-4  0.061
2014 Zigmond MJ, Fischer BA. Teaching responsible conduct responsibly. Journal of Microbiology & Biology Education. 15: 83-7. PMID 25574252 DOI: 10.1128/Jmbe.V15I2.874  0.058
1989 Bernath S, Keller RW, Zigmond MJ. Release of endogenous GABA can occur through Ca2+-dependent and Ca2+-independent processes Neurochemistry International. 14: 439-445. DOI: 10.1016/0197-0186(89)90033-8  0.056
2010 Cotman CW, Smith AD, Schallert T, Zigmond MJ. Exercise in Neurodegenerative Disease and Stroke Encyclopedia of Neuroscience. 123-131. DOI: 10.1016/B978-008045046-9.00499-X  0.054
1999 Fischer BA, Zigmond MJ. Do the right thing. Current Biology : Cb. 9: R1. PMID 9889130 DOI: 10.1016/S0960-9822(99)80026-8  0.053
2008 Zigmond M, Stabholz A, Shapira J, Bachrach G, Chaushu G, Becker A, Yefenof E, Merrick J, Chaushu S. Response to Dr S. S. A. Bekhit [2] Journal of Intellectual Disability Research. 52: 89-90. DOI: 10.1111/j.1365-2788.2007.00996.x  0.052
1999 Kerkut GA, Zigmond MJ. Progress in Neurobiology: Editorial Progress in Neurobiology. 57: iii. DOI: 10.1016/S0301-0082(98)00088-4  0.045
2006 Bachrach G, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, Merrick J, Chaushu S. Salivary LL-37 secretion in individuals with Down syndrome is normal. Journal of Dental Research. 85: 933-6. PMID 16998135  0.045
2000 Zigmond MJ, Belmonte C. Advice for a Young Investigator, by Santiago Ramón y Cajal (translated by Neely Swanson and Larry W. Swanson) Trends in Neurosciences. 23: 327-328. DOI: 10.1016/S0166-2236(00)01546-0  0.043
2014 Zigmond MJ, Rowland LP, Coyle JT. Neurobiology of brain disorders: Biological basis of neurological and psychiatric disorders Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. 1-801.  0.042
2011 Fischer BA, Zigmond MJ. Educational approaches for discouraging plagiarism. Urologic Oncology. 29: 100-3. PMID 21194645 DOI: 10.1016/J.Urolonc.2010.11.014  0.041
2010 Webster TS, Togna P, Hatzinger P, Zigmond M. Biological treatment of groundwater contaminated with n- nitrosodimethylamine (NDMA) using a fluidized bed reactor Awwa 2010 Inorganic Contaminants Workshop.  0.037
2012 Weidhaas JL, Zigmond MJ, Dupont RR. Aerobic biotransformation of N-Nitrosodimethylamine and N-nitrodimethylamine by benzene-,butane-, methane-, propane-, and toluene-fed cultures Bioremediation Journal. 16: 74-85. DOI: 10.1080/10889868.2012.665961  0.036
2001 Fischer BA, Zigmond MJ. Promoting responsible conduct in research through "survival skills" workshops: some mentoring is best done in a crowd. Science and Engineering Ethics. 7: 563-87. PMID 11697012 DOI: 10.1007/S11948-001-0014-X  0.035
2006 Zigmond M, Stabholz A, Shapira J, Bachrach G, Chaushu G, Becker A, Yefenof E, Merrick J, Chaushu S. The outcome of a preventive dental care programme on the prevalence of localized aggressive periodontitis in Down's syndrome individuals. Journal of Intellectual Disability Research : Jidr. 50: 492-500. PMID 16774634 DOI: 10.1111/j.1365-2788.2006.00794.x  0.034
1999 Zigmond MJ. Promoting responsible conduct: striving for change rather than consensus. Commentary on "Ambiguity, trust, and the responsible conduct of research" (F. Grinnell) Science and Engineering Ethics. 5: 219-28. PMID 11657860 DOI: 10.1007/S11948-999-0013-X  0.034
2003 Zigmond MJ. Implementing ethics in the professions: preparing guidelines on scientific communication for the Society for Neuroscience. Commentary on 'Implementing ethics in the professions: examples from environmental epidemiology' (Soskolne and Sieswerda). Science and Engineering Ethics. 9: 191-200. PMID 12774651 DOI: 10.1007/S11948-003-0006-0  0.033
2002 Zigmond MJ, Fischer BA. Beyond fabrication and plagiarism: the little murders of everyday science. Commentary on "Six Domains of Research Ethics". Science and Engineering Ethics. 8: 229-34. PMID 12092495 DOI: 10.1007/S11948-002-0024-3  0.033
2006 Fischer BA, Zigmond MJ. Toward a Climate of Scientific Integrity Plos Biology. 4: e84. DOI: 10.1371/Journal.Pbio.0040084  0.032
2010 Fischer BA, Zigmond MJ. The essential nature of sharing in science. Science and Engineering Ethics. 16: 783-99. PMID 21108019 DOI: 10.1007/S11948-010-9239-X  0.031
2010 Webster TS, Togna P, Hatzinger P, Zigmond M. Treatment of groundwater contaminated with N-Nitrosodimethylamine (NDMA) using a fluidized bed bioreactor Water Quality Technology Conference and Exposition 2010. 467-470.  0.03
2007 Chaushu S, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, Merrick J, Bachrach G. Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome. Archives of Oral Biology. 52: 1088-96. PMID 17658453 DOI: 10.1016/j.archoralbio.2007.06.002  0.028
2012 Webster T, Hatzinger P, Zigmond M. Bench and pilot treatment of groundwater contaminated with n-nitrosodimethylamine (NDMA) using a fluidized bed bioreactor Water Quality Technology Conference and Exposition 2012.  0.028
1992 Zigmond MJ, Spear LP. Neuroscience training in the USA and Canada: observations and suggestions. Trends in Neurosciences. 15: 379-83. PMID 1279858 DOI: 10.1016/0166-2236(92)90183-9  0.023
2004 Fischer BA, Zigmond MJ. Helping students get into graduate school. Journal of Undergraduate Neuroscience Education : June : a Publication of Fun, Faculty For Undergraduate Neuroscience. 3: A4-8. PMID 23493858  0.022
1985 Zigmond MJ. A Biological Introduction to Psychoactive Drugs Contemporary Psychology: a Journal of Reviews. 30: 448-449. DOI: 10.1037/023833  0.02
2018 Norris D, Dirnagl U, Zigmond MJ, Thompson-Peer K, Chow TT. Health tips for research groups. Nature. 557: 302-304. PMID 29769687 DOI: 10.1038/D41586-018-05146-5  0.02
1996 Fischer BA, Zigmond MJ. Teaching ethics: resources for researchers Trends in Neurosciences. 19: 523-524. DOI: 10.1016/S0166-2236(96)60036-8  0.017
2014 Zigmond MJ. Introduction Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. 733-734. DOI: 10.1016/B978-0-12-398270-4.00044-6  0.016
2014 Zigmond MJ, Rowland LP, Coyle JT. Preface Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. xiii-xiv. DOI: 10.1016/B978-0-12-398270-4.05001-1  0.015
2006 Stuart DG, Zigmond MJ. Preface Progress in Neurobiology. 78: 135. DOI: 10.1016/j.pneurobio.2006.04.003  0.015
2009 Weidhaas J, Macbeth T, Dupont RR, Zigmond M. Evaluation of the simultaneous cometabolic oxidation of NDMA, freons, and chlorinated solvents with multiple substrates In Situ and On-Site Bioremediation-2009: Proceedings of the 10th International in Situ and On-Site Bioremediation Symposium.  0.015
2009 Webster TS, Togna P, Hatzinger P, Zigmond M. Use of a fluidized-bed bioreactor for the treatment of N- nitrosodimethylamine (NDMA) in groundwater In Situ and On-Site Bioremediation-2009: Proceedings of the 10th International in Situ and On-Site Bioremediation Symposium.  0.015
1998 Loew FM, Zigmond MJ. Understanding planet Academia [1] (multiple letters) Nature Medicine. 4: 869.  0.012
2020 Zigmond MJ. Oleh Hornykiewicz: A Giant who Transformed Neuroscience over a 70-Year Career International Journal of Neuropsychopharmacology. 23: 545-547. DOI: 10.1093/ijnp/pyaa059  0.01
2014 Fischer BA, Grinnell F, Zigmond MJ. Introductory comments for the scientific ethics theme. Journal of Microbiology & Biology Education. 15: 82. PMID 25574251 DOI: 10.1128/Jmbe.V15I2.878  0.01
2011 Zigmond MJ. Making ethical guidelines matter American Scientist. 99: 296-299. DOI: 10.1511/2011.91.296  0.01
2007 Zigmond MJ. Angels and demons; heroes and villains Nature Medicine. 13: 1013-1013. DOI: 10.1038/NM0907-1013  0.01
1998 Zigmond MJ. Reply to “Understanding planet Academia” Nature Medicine. 4: 869-869. DOI: 10.1038/NM0898-869B  0.01
1998 Fischer BA, Zigmond MJ. Survival Skills for Graduate School and Beyond New Directions For Higher Education. 1998: 29-40. DOI: 10.1002/He.10103  0.01
1993 Kalaria RN, Zigmond MJ, Kimani JK. Out of Africa: first international meeting. Trends in Neurosciences. 16: 297-9. PMID 7691002 DOI: 10.1016/0166-2236(93)90102-R  0.01
1991 Zigmond MJ. Reply Trends in Neurosciences. 14: 183-185. DOI: 10.1016/0166-2236(91)90101-Y  0.01
Hide low-probability matches.